ENTA stock results show that Enanta Pharma beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024. More
Articles
CRSP Stock Earnings: CRISPR Therapeutics Beats EPS, Misses Revenue for Q2 2024
CRSP stock results show that CRISPR Therapeutics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. More
TERN Stock Earnings: Terns Pharma Beats EPS for Q2 2024
TERN stock results show that Terns Pharma beat analyst estimates for earnings per share the second quarter of 2024. More
ARTNA Stock Earnings: Artesian Resources Misses EPS, Beats Revenue for Q2 2024
ARTNA stock results show that Artesian Resources missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. More
SPGC Stock Earnings: Sacks Parente Golf Beats Revenue for Q2 2024
SPGC stock results show that Sacks Parente Golf beat on revenue for the second quarter of 2024. More
RCKT Stock Earnings: Rocket Pharmaceuticals Misses EPS for Q2 2024
RCKT stock results show that Rocket Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024. More
XNCR Stock Earnings: Xencor Misses EPS, Beats Revenue for Q2 2024
XNCR stock results show that Xencor missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. More
